SeaStar Medical Holding Statistics
Total Valuation
ICU has a market cap or net worth of $9.23 million. The enterprise value is -$4.53 million.
Important Dates
The next estimated earnings date is Friday, March 27, 2026, after market close.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU has 3.60 million shares outstanding. The number of shares has increased by 344.07% in one year.
| Current Share Class | 3.60M |
| Shares Outstanding | 3.60M |
| Shares Change (YoY) | +344.07% |
| Shares Change (QoQ) | +132.96% |
| Owned by Insiders (%) | 1.17% |
| Owned by Institutions (%) | 3.08% |
| Float | 3.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.47 |
| Forward PS | 5.81 |
| PB Ratio | 0.76 |
| P/TBV Ratio | 0.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.66
| Current Ratio | 3.66 |
| Quick Ratio | 3.44 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -290.37% and return on invested capital (ROIC) is -184.95%.
| Return on Equity (ROE) | -290.37% |
| Return on Assets (ROA) | -86.54% |
| Return on Invested Capital (ROIC) | -184.95% |
| Return on Capital Employed (ROCE) | -121.48% |
| Weighted Average Cost of Capital (WACC) | -1.32% |
| Revenue Per Employee | $46,368 |
| Profits Per Employee | -$719,211 |
| Employee Count | 19 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ICU has paid $3,000 in taxes.
| Income Tax | 3,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.38% in the last 52 weeks. The beta is -1.01, so ICU's price volatility has been lower than the market average.
| Beta (5Y) | -1.01 |
| 52-Week Price Change | -86.38% |
| 50-Day Moving Average | 2.50 |
| 200-Day Moving Average | 5.57 |
| Relative Strength Index (RSI) | 49.59 |
| Average Volume (20 Days) | 52,594 |
Short Selling Information
The latest short interest is 233,272, so 6.47% of the outstanding shares have been sold short.
| Short Interest | 233,272 |
| Short Previous Month | 286,335 |
| Short % of Shares Out | 6.47% |
| Short % of Float | 6.55% |
| Short Ratio (days to cover) | 2.64 |
Income Statement
In the last 12 months, ICU had revenue of $881,000 and -$13.67 million in losses. Loss per share was -$10.62.
| Revenue | 881,000 |
| Gross Profit | 840,000 |
| Operating Income | -13.93M |
| Pretax Income | -13.66M |
| Net Income | -13.67M |
| EBITDA | n/a |
| EBIT | -13.93M |
| Loss Per Share | -$10.62 |
Full Income Statement Balance Sheet
The company has $13.76 million in cash and n/a in debt, with a net cash position of $13.76 million or $3.82 per share.
| Cash & Cash Equivalents | 13.76M |
| Total Debt | n/a |
| Net Cash | 13.76M |
| Net Cash Per Share | $3.82 |
| Equity (Book Value) | 11.46M |
| Book Value Per Share | 3.36 |
| Working Capital | 10.81M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -14.20M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
| Gross Margin | 95.35% |
| Operating Margin | -1,580.70% |
| Pretax Margin | -1,550.74% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ICU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -344.07% |
| Shareholder Yield | -344.07% |
| Earnings Yield | -148.08% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 5, 2026. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jan 5, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
ICU has an Altman Z-Score of -13.36 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.36 |
| Piotroski F-Score | 2 |